Mutual Accupril Declaratory Judgment Case Versus Pfizer Thrown Out; Teva Exclusivity Intact
This article was originally published in The Pink Sheet Daily
Executive Summary
The court’s ruling means that Mutual cannot obtain a judgment that could potentially trigger Teva’s 180-day marketing exclusivity for the first generic version of Pfizer’s ACE inhibitor quinapril.